Cargando…
Prognostic Value of CXCL12 in Non-Small Cell Lung Cancer Patients Undergoing Tumor Resection
Adjuvant chemotherapy is commonly indicated in lung cancer patients undergoing surgical therapy because tumor recurrence is frequent. A biomarker that can predict tumor recurrence in the postoperative period is currently unavailable. CXCR4 receptor and its ligand CXCL12 play important roles in metas...
Autores principales: | Kogue, Yurie, Kobayashi, Hiroyasu, Nakamura, Yutaka, Takano, Takatsugu, Furuta, Chihiro, Kawano, Osamu, Yasuma, Taro, Nishimura, Tadashi, D’Alessandro-Gabazza, Corina N., Fujimoto, Hajime, Gabazza, Esteban C., Kobayashi, Tetsu, Fukai, Ichiro |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9967107/ https://www.ncbi.nlm.nih.gov/pubmed/37227446 http://dx.doi.org/10.3390/ph16020255 |
Ejemplares similares
-
Too Premature to Deny the Potential of Thrombomodulin Alfa in Idiopathic Pulmonary Fibrosis
por: Kobayashi, Tetsu, et al.
Publicado: (2020) -
Response of Lung Microbiota to Changes of Pulmonary Innate Immunity under Healthy Conditions
por: Yasuma, Taro, et al.
Publicado: (2021) -
The Need for a CYFRA 21-1 Cutoff Value to Predict Clinical Progression of IPF in Clinical Practice
por: Fujimoto, Hajime, et al.
Publicado: (2022) -
Microbial Burden-associated Cytokine Storm May Explain Nonresolving Acute Respiratory Distress Syndrome in Patients with COVID-19
por: Yasuma, Taro, et al.
Publicado: (2022) -
Is the Urokinase Plasminogen Activator/Plasminogen Activator Inhibitor-1 Ratio a Marker of Sonographic Septations in Pleural Infection?
por: Yasuma, Taro, et al.
Publicado: (2022)